Pharmaceutical Contract Development and Manufacturing Market Research Report 2022: Industry is expected to reach $30.36 Billion by 2027 at a CAGR of 8.52% – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The report “Pharma Contract Development and Manufacturing Market Research Report by Service, End User, State – US Forecast to 2027 – Cumulative Impact of COVID-19” has been added to from ResearchAndMarkets.com offer.

The United States Pharmaceutical Contract Development and Manufacturing market size was estimated at USD 18.58 billion in 2021 and is projected to reach USD 20.09 billion in 2022, and is projected to grow at a compound annual growth rate ( CAGR) of 8.52% to reach 30.36 billion USD. by 2027.

Segmentation and market coverage:

This research report categorizes the development and manufacturing of Pharmaceutical Contracts to forecast revenue and analyze trends in each of the following submarkets:

  • On the basis of service, the market has been studied in biologics manufacturing services, drug development services, pharmaceutical manufacturing services, and secondary packaging services. Biologics manufacturing services are further explored in Biologics API Manufacturing Services and Biologics FDF Manufacturing Services. Pharmaceutical manufacturing services are further explored in Pharmaceutical API Manufacturing and Pharmaceutical FDF Manufacturing. Pharmaceutical API manufacturing is further explored in capsule manufacturing services, oral liquid manufacturing services, parenteral/injectables manufacturing services, and tablet manufacturing services.

  • On the basis of end-user, the market has been studied across large pharmaceutical companies, generic pharmaceutical companies, and small and medium pharmaceutical companies.

  • Based on the state, the market has been studied in California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Main topics covered:

1. Preface

2. Research methodology

3. Executive Summary

4. Market Overview

5. Market Overview

5.1. Market dynamics

5.1.1. Drivers

5.1.2. Constraints

5.1.3. Opportunities

5.1.4. Challenges

5.2. Cumulative impact of COVID-19

6. Pharmaceutical Contract Development and Manufacturing Market, By Service

6.1. Introduction

6.2. Biologics Manufacturing Services

6.2.1. Biologics API Manufacturing Services

6.2.2. Biologics FDF Manufacturing Services

6.3. Drug Development Services

6.4. Pharmaceutical Manufacturing Services

6.4.1. Manufacture of pharmaceutical API

6.4.1.1. Capsule manufacturing services

6.4.1.2. Oral Liquid Manufacturing Services

6.4.1.3. Parenteral/Injectables Manufacturing Services

6.4.1.4. Tablet Manufacturing Services

6.4.2. FDF Pharmaceutical Manufacturing

6.5. Secondary packaging services

7. Pharmaceutical Contract Development and Manufacturing Market, By End User

7.1. Introduction

7.2. Large Pharmacy

7.3. Generic pharmaceutical companies

7.4. Small and medium pharmaceutical companies

8. California Pharmaceutical Contract Development and Manufacturing Market

9. Florida Pharmaceutical Contract Development and Manufacturing Market

10. Illinois Pharmaceutical Contract Development and Manufacturing Market

11. New York Pharmaceutical Contract Development and Manufacturing Market

12. Ohio Pharmaceutical Contract Development and Manufacturing Market

13. Pennsylvania Pharmaceutical Contract Development and Manufacturing Market

14. Texas Pharmaceutical Contract Development and Manufacturing Market

15. Competitive landscape

15.1. FPNV positioning matrix

15.1.1. Quadrants

15.1.2. Business strategy

15.1.3. Product Satisfaction

15.2. Market Ranking Analysis

15.3. Market share analysis, by key player

15.4. Competitive scenario

15.4.1. Merger & Acquisition

15.4.2. Agreement, collaboration and partnership

15.4.3. Launching and improving new products

15.4.4. Investment & Financing

15.4.5. Reward, recognition and expansion

Companies cited

  • AbbVie, Inc.

  • Aenova Group GmbH

  • Almac Group

  • Global AMRI

  • CH Boehringer Sohn AG & Ko. KG

  • Cambrex Corporation

  • Catalent, Inc.

  • Danaher Corporation

  • Delwis Healthcare Pvt Ltd.

  • Evonik Industries AG

  • Famar Health Services

  • Fareva

  • Jubilant Life Sciences Limited

  • Lonza Group AG

  • Pfizer Inc.

  • Recipharm AB

  • Serum Institute of India Ltd.

  • Siegfried Holding AG

  • Thermo Fisher Scientific Inc.

  • Vetter Pharma-Fertigung GmbH & Co. KG

For more information about this report visit https://www.researchandmarkets.com/r/xv2cmp

About Barbara J. Ross

Check Also

HVAC Market Size 2022 with Industry Development Scenario

2022-2032 HVAC Industry Scope | overviewSLICE HVAC Market research by insightSLICE offers insightful findings on …